First Page | Document Content | |
---|---|---|
Date: 2010-04-26 15:39:48Rare diseases National Institutes of Health Lysosomal storage disease Blood–brain barrier National Institute of Neurological Disorders and Stroke Gene therapy Alpha-mannosidosis Biology Medicine Health | NNPDF-Funded Research Grant # 46 TITLE: Additional contribution to LSD Research Consortium for research into issues of common interest to all LSD support groups (See also Grant # 40) PROJECT INVESTIGATOR: Multiple PERIODAdd to Reading ListSource URL: www.nnpdf.orgDownload Document from Source WebsiteFile Size: 201,35 KBShare Document on Facebook |
How one patient with a rare disease coped with his genetic disorderDocID: 1r9mW - View Document | |
CrossMark_Color_flat+clickDocID: 1r0lC - View Document | |
What is HUNTER SYNDROME? Hunter syndrome, or mucopolysaccharidosis II (MPS II), is a rare and progressive lysosomal storage disease inherited in an X-linked recessiveDocID: 1lIxr - View Document | |
MUCOPOLYSACCHARIDOSES Rare Diseases Unit of the Finnish Association of People with Physical Disabilities Support for this guide was provided by Genzyme.DocID: 1fJSQ - View Document | |
May 27, 2014 BioMarin Doses First Patient in Phase 3 INSPIRE Trial With BMN 701 for the Treatment of Pompe Disease Proprietary Glycosylation Independent Lysosomal Targeting (GILT) Tagging Technology Has Been Shown to ImDocID: 1aiEg - View Document |